Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Interventional
Official Title: A Phase II, Open-label, Single-arm, Multi-cohort, Proof-of-principle Study to Investigate the Efficacy of Cobimetinib and Atezolizumab in Advanced Rare Tumors
Brief Summary:
The goal of the main part of this clinical research study is to learn if cobimetinib and atezolizumab can help to control advanced rare tumors.
The goal of this continuation part of the clinical research study is to allow patients in the main study of Protocol 2016-0869 to continue receiving the study drug(s) if the tumor grows or worsens to continue to study the effects of cobimetinib and atezolizumab.